193 related articles for article (PubMed ID: 37091184)
41. Method for the extraction of circulating nucleic acids based on MOF reveals cell-free RNA signatures in liver cancer.
Sun Y; Yu H; Han S; Ran R; Yang Y; Tang Y; Wang Y; Zhang W; Tang H; Fu B; Fu B; Weng X; Liu SM; Deng H; Peng S; Zhou X
Natl Sci Rev; 2024 Jan; 11(1):nwae022. PubMed ID: 38348130
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.
Wang QQ; Zhou YC; Zhou Ge YJ; Qin G; Yin TF; Zhao DY; Tan C; Yao SK
World J Clin Cases; 2022 Aug; 10(22):7686-7697. PubMed ID: 36158487
[TBL] [Abstract][Full Text] [Related]
43. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
44. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q
Front Genet; 2022; 13():851373. PubMed ID: 35401707
[No Abstract] [Full Text] [Related]
45. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
[TBL] [Abstract][Full Text] [Related]
46. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer.
Wang L; Duan W; Yan S; Xie Y; Wang C
Biomed Pharmacother; 2019 May; 113():108758. PubMed ID: 30877883
[TBL] [Abstract][Full Text] [Related]
47. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
48. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
[TBL] [Abstract][Full Text] [Related]
49. Identification of prognostic long intergenic non-coding RNAs as competing endogenous RNAs with KRAS mutations in colorectal cancer.
Xu J; Huang QY; Ge CJ
Oncol Lett; 2021 Oct; 22(4):717. PubMed ID: 34429757
[TBL] [Abstract][Full Text] [Related]
50. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
Front Immunol; 2021; 12():778329. PubMed ID: 34975867
[TBL] [Abstract][Full Text] [Related]
51. A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer.
Kim SK; Kim SY; Kim CW; Roh SA; Ha YJ; Lee JL; Heo H; Cho DH; Lee JS; Kim YS; Kim JC
Exp Mol Med; 2019 Oct; 51(10):1-12. PubMed ID: 31578316
[TBL] [Abstract][Full Text] [Related]
52. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers.
Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer.
Pan H; Pan J; Wu J
Front Immunol; 2022; 13():934221. PubMed ID: 35967425
[TBL] [Abstract][Full Text] [Related]
54. RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
Mini E; Lapucci A; Perrone G; D'Aurizio R; Napoli C; Brugia M; Landini I; Tassi R; Picariello L; Simi L; Mancini I; Messerini L; Magi A; Pinzani P; Mazzei T; Tonelli F; Nobili S
Int J Cancer; 2019 Nov; 145(9):2580-2593. PubMed ID: 30973654
[TBL] [Abstract][Full Text] [Related]
55. Polyadenylation ligation-mediated sequencing (PALM-Seq) characterizes cell-free coding and non-coding RNAs in human biofluids.
Liu Z; Wang T; Yang X; Zhou Q; Zhu S; Zeng J; Chen H; Sun J; Li L; Xu J; Geng C; Xu X; Wang J; Yang H; Zhu S; Chen F; Wang WJ
Clin Transl Med; 2022 Jul; 12(7):e987. PubMed ID: 35858042
[TBL] [Abstract][Full Text] [Related]
56. Identifying Differentially Expressed tRNA-Derived Small Fragments as a Biomarker for the Progression and Metastasis of Colorectal Cancer.
Chen H; Xu Z; Cai H; Peng Y; Yang L; Wang Z
Dis Markers; 2022; 2022():2646173. PubMed ID: 35035608
[TBL] [Abstract][Full Text] [Related]
57. A qualitative transcriptional signature for the early diagnosis of colorectal cancer.
Guan Q; Zeng Q; Yan H; Xie J; Cheng J; Ao L; He J; Zhao W; Chen K; Guo Y; Guan G; Guo Z
Cancer Sci; 2019 Oct; 110(10):3225-3234. PubMed ID: 31335996
[TBL] [Abstract][Full Text] [Related]
58. Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer.
Wang XC; Liu Y; Long FW; Liu LR; Fan CW
Future Oncol; 2021 Aug; 17(23):3087-3100. PubMed ID: 33910362
[TBL] [Abstract][Full Text] [Related]
59. Decoding cell-type contributions to the cfRNA transcriptomic landscape of liver cancer.
Safrastyan A; Zu Siederdissen CH; Wollny D
Hum Genomics; 2023 Oct; 17(1):90. PubMed ID: 37798661
[TBL] [Abstract][Full Text] [Related]
60. Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors.
Wang R; Li J; Zhou X; Mao Y; Wang W; Gao S; Wang W; Gao Y; Chen K; Yu S; Wu X; Wen L; Ge H; Fu W; Tang F
Genome Med; 2022 Aug; 14(1):93. PubMed ID: 35974387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
